* . * . . .
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Cookie Privacy Policy
  • DMCA
  • California Consumer Privacy Act (CCPA)
Friday, May 30, 2025
Love Europe
  • Politics
  • Business
  • Culture
  • Opinion
  • Lifestyle
  • Sports
  • Travel
No Result
View All Result
  • Politics
  • Business
  • Culture
  • Opinion
  • Lifestyle
  • Sports
  • Travel
No Result
View All Result
Love Europe
No Result
View All Result
Home Germany

Mpox: European health authorities say risk to public is low after new strain identified in Germany

October 24, 2024
in Germany
Mpox: European health authorities say risk to public is low after new strain identified in Germany
Share on FacebookShare on Twitter
ADVERTISEMENT

The ECDC said it is “monitoring the situation closely” but that “the risk of sustained transmission of mpox in Europe remains low”.

The first case of the new variant, called clade 1b, was previously identified in Sweden in August. No other cases have been reported in Europe, though the ECDC said at the time it was likely there would be more imported cases because of travel between Europe and Africa.

Despite the low risk to the public, the ECDC said European countries should adopt “enhanced preparedness, continued vigilance and rapid implementation of control measures upon case detection” to prevent further spread.

Health authorities have been on high alert about clade 1b because it is at the centre of an outbreak that has been ravaging the Democratic Republic of the Congo (DRC) since last autumn and has since spread to other countries in the region.

As of mid-October, more than 42,000 mpox cases and nearly 1,000 deaths have been reported in 18 African countries. That includes all mpox cases, not just those from the clade 1b strain.

Mpox spreads through close physical contact and can cause a rash, lymph node swelling, and fever. A vaccine is available, though delays in immunisations have slowed the public health response in Africa.

“Travellers to areas affected by the mpox outbreak should consult their healthcare provider or travel health clinic regarding eligibility for vaccination against mpox,” the ECDC said.

Source link : https://www.euronews.com/health/2024/10/23/mpox-european-health-authorities-say-risk-to-public-is-low-after-new-strain-identified-in-

Author :

Publish date : 2024-10-23 14:26:00

Copyright for syndicated content belongs to the linked Source.

Tags: EuropeGermany
ADVERTISEMENT
Previous Post

NATO – Hungary and NATO

Next Post

France hosts Lebanon aid conference in Paris

Related Posts

Germany

Sinti and Roma kids undergo discrimination – DW – EUROP INFO

Germany

Germany Has Granted Over Half a Million Work Visas within the Final 4 Years – Schengen.Information – EUROP INFO

Germany

Vestas unveils 376 MW of onshore orders in US, Germany, Italy – Renewables Now – EUROP INFO

ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianpt Portugueseru Russianes Spanish
en English
ADVERTISEMENT

Highlights

A Rising Star Shaping UCLA Anderson’s MBA Class of 2026 – EUROP INFO

Five Skiers Found Dead Near Prestigious Swiss Resort – EUROP INFO

Lakers to Send Coach to Slovenia for Face-to-Face with Luka Doncic – EUROP INFO

Spain’s Sánchez Urges von der Leyen to Take Immediate Action Against Israel’s ‘Illegal Invasion’ of Gaza – EUROP INFO

Japan and Italy Soar to New Heights in Slovenia Showdown – EUROP INFO

Categories

Select Category

    Archives

    Select Month
      October 2024
      MTWTFSS
       123456
      78910111213
      14151617181920
      21222324252627
      28293031 
      « Sep   Nov »
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Cookie Privacy Policy
      • DMCA
      • California Consumer Privacy Act (CCPA)
      No Result
      View All Result
      • Home
      • Politics
      • News
      • Business
      • Culture
      • Sports
      • Lifestyle
      • Travel
      • Opinion

      © 2024 Love-Europe

      This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
      Go to mobile version